Pathfinder Cell Therapy, Inc.
OTC: PFND0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard L. Franklin
- Employees
- 1
- Headquarters
- Cambridge, United States
- IPO year
- 2000
- Market cap
- $66.7K
- Website
- https://www.pathfindercelltherapy.com
Loading PFND…
Loading profile data…Frequently asked questions about PFND
What does Pathfinder Cell Therapy, Inc. (PFND) do?
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology...
Where does PFND trade?
Pathfinder Cell Therapy, Inc. (PFND) trades on the Other OTC.
What sector is PFND in?
Pathfinder Cell Therapy, Inc. (PFND) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pathfinder Cell Therapy, Inc.?
Richard L. Franklin is the chief executive officer of Pathfinder Cell Therapy, Inc. (PFND).
Where is Pathfinder Cell Therapy, Inc. headquartered?
Pathfinder Cell Therapy, Inc. is headquartered in United States.
Does PFND pay a dividend?
Pathfinder Cell Therapy, Inc. (PFND) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PFND go public?
Pathfinder Cell Therapy, Inc. (PFND) completed its initial public offering in 2000.